Physician profile
Jeffrey A Orr
NPI 1962792952
$13,381.22
in general payments reported to CMS, 2019-2025
16 companies · $404 in 2025
The $404 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,145 · 2020: $2,118 · 2021: $2,504 · 2022: $3,414 · 2023: $701 · 2024: $1,094 · 2025: $404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,103 · Travel and Lodging: $96.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,102.50 |
| Travel and Lodging | $96.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,285.60 | 2019-2025 | Mako, Simplex, Augment Injectable |
| Evolution Surgical, INC | $2,908.68 | 2022-2024 | |
| Sequoia Surgical, INC. | $2,879.00 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $1,800.52 | 2019-2021 | |
| Arthrex, INC. | $1,455.10 | 2021-2024 | |
| Depuy Synthes Sales INC. | $541.01 | 2019-2025 | Unium, Na, Motoband |
| Goode Surgical INC | $180.16 | 2025 | |
| Miach Orthopaedics, INC. | $147.42 | 2022 | |
| Bioventus LLC | $46.95 | 2024 | Durolane |
| Avanos Medical | $29.02 | 2023 | Grpro 2.1 |
| Trice Medical, INC. | $23.06 | 2025 | |
| Vericel Corporation | $20.60 | 2023 | Maci |
| Heraeus Medical, LLC. | $18.55 | 2023 | Palacos |
| Vertex Pharmaceuticals Incorporated | $17.00 | 2025 | |
| Smith+Nephew, INC. | $15.19 | 2025 | Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $13.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Orr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.